Since the glioma in mouse brain showed that mRNA levels of PD-L1 were lower in the paliperidone treatment group, we further determined whether DRD2 expressed in mouse GBM changes the polarization of TAMs under interaction of GBM and macrophages. The gene discussed is DRD2; the disease is central nervous system cancer.